Skip to main content
. 2015 Mar 14;6(12):10320–10334. doi: 10.18632/oncotarget.3583

Table 1. Tumorigenic potential of indicated MEFs in vivo.

E1A/Ras Hipk2+/+ E1A/Ras Hipk2−/−
Injected cell number 2×106 5×106 1×107 2×107 1×103 1×104 5×105 2×106
Tumor incidence 0/5 0/5 0/5 3/3 0/3 1/3 3/5 5/5
Tumor appearance n.a. n.a. n.a. 7 n.a. 13 5 5

Tumor incidence is reported as tumor bearing mice/number of injected mice. Tumor appearance is reported as days post injection. n.a., not applicable.